A rare case of non-traumatic spinal epidural hematoma in lumbar region associated with apixaban therapy

J Thromb Thrombolysis. 2021 Nov;52(4):1215-1219. doi: 10.1007/s11239-021-02462-y. Epub 2021 May 6.

Abstract

Spontaneous spinal epidural hematoma (SSEH) is a very rare clinical entity with potential diagnostic difficulties and which can result in severe neurological deficit. The etiology of this rare condition is largely not known, but with potential predisposition in patients on anticoagulation medication. This includes the novel anticoagulants with direct inhibition of the factor Xa mechanism (DOACs). These medications are supposed to have more predictable pharmacokinetics with fewer severe haemorrhagic adverse events in comparison with standard warfarin therapy. However, in the last few years, an increasing number of case reports have been published of haemorrhage into the central nervous system. We present a case of non-traumatic spinal epidural hematoma in the lumbar region in a patient on chronic apixaban therapy. To the best of our knowledge, it is the first described SSEH in the lumbar region associated with apixaban therapy.

Keywords: Anticoagulation; Apixaban; Non-traumatic spinal epidural hematoma; Novel oral anticoagulants.

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants
  • Hematoma, Epidural, Spinal* / chemically induced
  • Hematoma, Epidural, Spinal* / diagnostic imaging
  • Humans
  • Lumbosacral Region
  • Magnetic Resonance Imaging
  • Pyrazoles / adverse effects*
  • Pyridones / adverse effects*

Substances

  • Anticoagulants
  • Pyrazoles
  • Pyridones
  • apixaban

Grants and funding